Equine arteritis virus (EAV) causes a persistent infection of the reproductive tract of carrier stallions. The authors determined the complete genome sequences of viruses (CW96 and CW01) that were present 5 years apart in the semen of a carrier stallion (CW). The CW96 and CW01 viruses respectively had only 85?6 % and 85?7 % nucleotide identity to the published sequence of EAV (EAV030). The CW96 and CW01 viruses had two 1 nt insertions and a single 1 nt deletion in the leader sequence, and a 3 nt coding insertion in ORF1a; thus their genomes included 12 708 nt as compared to the 12 704 nt in EAV030. Variation between viruses present in the semen of stallion CW and EAV030 was especially marked in the replicase gene (ORF1a and 1b), and the greatest variation occurred in the portion of ORF1a encoding the nsp2 protein. The ORFs 3 and 5, which respectively encode the GP3 and GP5 envelope proteins, showed greatest variation amongst ORFs encoding structural EAV proteins. Comparative sequence analyses of CW96 and CW01 indicated that ORFs 1a, 1b and 7 were highly conserved during persistent infection, whereas there was substantial variation in ORFs 3 and 5. Although the variation that occurs in ORF5 results in the emergence of novel phenotypic viral variants as determined by neutralization assay, all variants were neutralized by high-titre polyclonal equine antisera, suggesting that immune evasion is unlikely to be responsible for the establishment of persistent EAV infection of carrier stallions. Northern blot analyses of RNA extracted from cell culture propagated viruses isolated from 10 different persistently infected stallions failed to demonstrate any large genomic deletions, suggesting that defective interfering particles are also unlikely to be important in either the maintenance or clearance of persistent EAV infection of the reproductive tract of carrier stallions.
INTRODUCTION
Equine viral arteritis (EVA) is a reproductive and respiratory disease of horses, donkeys and mules that is caused by equine arteritis virus (EAV; Timoney & McCollum, 1993) . EAV infection of horses is endemic in much of the world and results in occasional outbreaks of respiratory disease in adult horses, abortion in pregnant mares, and interstitial pneumonia in young foals (Glaser et al., 1996 (Glaser et al., , 1997 Timoney, 1999; Timoney & McCollum, 1993) . Clinical signs of EAV infection can vary markedly between outbreaks Patton et al., 1999; Balasuriya et al., 1998 , but most EAV infections are subclinical. Many stallions become persistently infected carriers following EAV infection and continue to shed the virus in their semen for variable periods of time (Timoney, 1999; Timoney & McCollum, 1993; Timoney et al., 1986 Timoney et al., , 1987 .
EAV is the prototype virus in the family Arteriviridae, genus Arterivirus, which also includes porcine reproductive and respiratory syndrome virus (PRRSV), simian haemorrhagic fever virus, and lactate dehydrogenase elevating virus of mice (Snijder, 2001) . The family Arteriviridae is included in the order Nidovirales, together with the Coronaviridae and Roniviridae (Cowley & Walker, 2002; de Vries et al., 1997; Cavanagh, 1997; Jitrapakdee et al., 2003; Snijder, 2001; Snijder et al., 2001) . The only available full-length EAV genome sequence is derived from a highly cell culture adapted, North American isolate (den Boon et al., 1991;  GenBank accession number X53459) and was subsequently used to engineer an EAV infectious cDNA clone (pEAV030, GenBank accession number Y07862; van Dinten et al., 1997) . In this paper this virus will be referred to as EAV030. The EAV genome is a positive-stranded RNA molecule (approx. 12?7 kb) and includes nine open reading frames (ORFs) (den Boon et al., 1991; van Dinten et al., 1997) . The two most 59-proximal ORFs (1a and 1b) occupy approximately three-quarters of the genome and encode two replicase proteins (1a and 1ab) that are post-translationally processed into at least 12 nonstructural proteins (nsp1-12; van Dinten, 1999; Snijder & Meulenberg, 1998; Ziebuhr et al., 2000) . The remaining seven ORFs (2a, are located in the 39-proximal quarter of the genome and encode seven structural proteins (E, GP2, GP3, GP4, GP5, M and N respectively; de Vries et al., 1992; Snijder et al., 1999; Snijder, 2001; Wieringa et al., 2003) . The EAV particle consists of a nucleocapsid (N) protein that forms the icosahedral core, and six envelope proteins. The envelope contains two principal viral proteins, the GP5 major envelope glycoprotein (30-44 kDa; encoded by ORF5) and the unglycosylated membrane protein M (17 kDa; encoded by ORF6). The M and GP5 proteins form a disulfide-linked heterodimer, and this interaction is critical for virus infectivity and expression of the neutralization determinants in authentic form (Balasuriya et al., 1993 (Balasuriya et al., , 1995a (Balasuriya et al., , 1997 (Balasuriya et al., , 2000 (Balasuriya et al., , 2002 Deregt et al., 1994; de Vries et al., 1995; Glaser et al., 1995; Snijder et al., 2003) . In addition, the EAV envelope contains a heterotrimer of three minor membrane glycoproteins designated as GP2, GP3 and GP4 (25 kDa, 36-42 kDa and 28 kDa; encoded by ORFs 2b, 3 and 4 respectively) and an unglycosylated envelope protein E (8 kDa; encoded by ORF2a; Snijder et al., 1999; Wieringa et al., 2003) .
EAV causes a long-term persistent infection that is specifically localized to the ampulla of the reproductive tract of carrier stallions (Timoney & McCollum, 1993; Timoney et al., 1986 Timoney et al., , 1987 . Infectious virus is continuously shed in the semen of carrier stallions, despite high titres of neutralizing antibodies in their serum. Persistently infected stallions act as a natural reservoir of EAV and transmit the virus to susceptible mares during artificial or natural breeding Balasuriya et al., 1998 . Persistently infected carrier stallions can cease to shed virus in their semen weeks to years after infection with no apparent later reversion to a shedding state; however, the mechanism responsible for this spontaneous clearance of EAV from persistently infected stallions is undefined (Timoney & McCollum, 1993) . EAV evolves in the course of persistent infection at a rate of approximately 1 % nucleotide substitutions per 2822 nt (ORFs 2-7) per year, leading to emergence of novel genotypic and phenotypic variants (Hedges et al., 1999b) . ORF5 varies markedly between strains of EAV, and large numbers of point mutations and occasional deletions were previously identified in ORF5 amplified from the semen of persistently infected stallions Glaser et al., 1995; Hedges et al., 1999b) . The objectives of this study were to characterize the evolution of the entire virus genome during persistent EAV infection, and the possible emergence of defective interfering (DI) virus particles. Although DI particles have been implicated in the pathogenesis of persistent infections caused by a number of RNA viruses (Roux et al., 1991) , their true significance in maintaining or terminating persistent virus infections of animals is still unclear (Drolet et al., 1995; Huang & Baltimore, 1970 , 1977 Tautz et al., 1994) .
METHODS
Cells. Baby hamster kidney 21 cells (BHK-21; ATCC CCL 10) were maintained in Eagle's medium (EMEM) supplemented with 10 % fetal bovine serum (FBS; Hyclone Laboratories), 10 % tryptose phosphate broth and 1 % penicillin-streptomycin. Rabbit kidney 13 (RK-13; ATCC CCL 37) cells were maintained in EMEM supplemented with 10 % calf serum (Hyclone Laboratories) and antibiotics.
Stallions and viruses. Archived semen samples previously collected from EAV carrier stallions were evaluated (Table 1) , including a Holsteiner stallion (CW) imported to the United States from Europe in 1995, as well as two Standardbred (FLS and KS), a Westfalen (RS), a pony (P) and five Thoroughbred stallions (D, E, RC, SS and WHB) that all were resident in North America. Semen samples were diluted (10 21 , 10 22 and 10
23
) and inoculated onto RK-13 cell monolayers for virus isolation, as previously described (Balasuriya et al., 1998) . EAV isolated from these semen samples was identified by microneutralization assay using monoclonal antibodies (mAbs) and polyclonal equine sera to the virus. Viruses contained in individual semen samples are identified by stallion and year of isolation (e.g. CW96).
To evaluate the possible presence of DI viruses in the semen of carrier stallions, BHK-21 cells were infected at a m.o.i. of 25-50 with strains of EAV isolated from individual carrier stallions (RK-13 passage 1 or 2). Tissue culture fluid was harvested after incubation for 36-48 h at 37 uC, at which time complete cytopathic effect was evident. Each virus was serially passaged (undiluted) six times in BHK-21 cells for extraction of RNA for Northern hybridization assay.
The prototype Bucyrus strain [ATCC (ATCC VR-796)] of EAV was used as a control virus in the neutralization assay, and for extraction of RNA for the development of Northern hybridization probes. The DI virus derived from the pED1 clone (Molenkamp et al., 2000) was also used as a control in the Northern hybridization assay.
Microneutralization assay. The EAV microneutralization assay was performed as previously described (Balasuriya et al., 1995a (Balasuriya et al., , 1997 . Neutralization titres were determined for each virus isolated from the semen of individual carrier stallions using a panel of EAVspecific mAbs and polyclonal equine antisera.
Isolation of viral RNA, RT-PCR amplification and sequencing.
Viral RNA was directly isolated from infected BHK-21 cell cultures or from the semen of persistently infected stallions using the QIAmp Viral RNA isolation kit (Qiagen). ORF 5 with flanking portions of ORFs 4 and 6 from each strain of EAV was amplified by RT-PCR. The entire genome of the CW96 and CW01 strains of EAV contained in the semen of stallion CW (in 1996 and 2001 respectively) were amplified in nine overlapping segments. RT-PCR amplifications were performed with Superscript II (Invitrogen Life Science Products) and Pfu Turbo DNA polymerase (Stratagene) as previously described . The 59 and 39 ends of CW96 and CW01 were amplified with the SMART Race cDNA amplification kit (Clontech) according to the manufacturer's protocol. The PCR products were gel-purified and both sense and anti-sense strands were sequenced with the PRISM Ready Reaction DyeDeoxy Terminator cycle sequencing kit (Applied Biosystems) as previously described.
Sequence and phylogenetic analysis. Sequence data were analysed with the Sequencher 3.0 (Gene Codes), HIBIO MacDNASIS pro version 3.5 (Hitachi) and Vector NTI Suite V.6 (InforMax) software programs. Phylogenetic analyses were performed as previously described (Balasuriya et al., 1995b , using the Phylogenetic Inference Package (PHYLIP; Felsenstein, 1993) . Estimates of the number of synonymous and nonsynonymous nucleotide changes and the number of nonsynonymous substitutions per nonsynonymous site (dN) and synonymous substitutions per synonymous site (dS) were estimated using the MEGA 2.0 program (Kumar et al., 2001) . The dN/dS ratios were calculated for each nonstructrural and structural protein gene by the Li-Wu-Luo method (Li et al., 1985; Yang & Nielsen, 2000) .
Analysis of viral RNA by Northern hybridization assay. The possible emergence of DI viruses in the semen of EAV carrier stallions was evaluated by Northern hybridization assay. Two anti-sense RNA probes (nt 1-300 and 212-550) were developed to the leader sequence and the 59 end of the ORF1a of the ATCC strain of EAV for use in the Northern hybridization assay. The first probe reacts with the common leader sequence (nt 1-224) that is present in all seven viral mRNAs and also in the published EAV DI RNAs (Molenkamp et al., 2000) . The second probe is expected to react only with genomic RNA, and with DI RNAs which are likely to have retained this region (nt 212-550) of the genome because it contains important replication signals (Tijms et al., 2001 ). Viral RNA was directly isolated from tissue culture fluid containing the EAV ATCC virus and the leader sequence was amplified with two primer pairs (Table 2) using the QIAgen OneStep RT-PCR kit. The gel-purified RT-PCR products were cloned into a linearized plasmid vector with overhanging 39 T residues (TOPO TA cloning kit, Invitrogen Life Science Products). The plasmids were purified using a commercial kit (QIAmp Miniprep kit) and the authenticity and orientation of the leader sequence were determined by sequencing of both strands of DNA with M13 reverse and forward primers. Plasmid DNA (1 mg) was linearized with BamHI, phenol/chloroform extracted and resuspended in nuclease-free water. Digoxigenin (DIG)-labelled RNA probes were made using the DIG RNA labelling kit according to the manufacturer's instructions (Roche). The plasmid DNA was removed by digestion with RNase-free DNase I (Pharmacia) for 15 min at 37 uC.
Intracellular RNA was isolated at 24 h post-infection of BHK-21 cells with each virus strain isolated from the semen of EAV carrier stallions [BHK-21 passage 1 and 6 (BHK1 and BHK6)]. Briefly, the infected cells were scraped and pelleted at 3000 g for 15 min. EAV-infected cells were washed once in phosphate-buffered saline (pH 7?5). The cell pellet was then resuspended in 400 ml RNAlater (Ambion) and stored at 280 uC until RNA was extracted with the RNAqueous-4PCR (Ambion) kit according to the manufacturer's protocol. The RNA was eluted in 60 ml elution buffer and contaminating DNA was removed by RNase-free DNase I (Pharmacia) treatment at 37 uC for 15 min. RNA was precipitated with lithium chloride, washed once with 70 % ethanol, resuspended in 20 ml nuclease-free water and stored at 280 uC. Denaturing RNA electrophoresis was carried out using 1 % agarose gels containing formaldehyde (NorthernMax; Ambion). RNA was transferred to a positively charged nylon membrane (Roche) using a VacuGene XL vacuum blotting system (Amersham Pharmacia Biotech) and hybridized with a DIG-labelled RNA probe specific for the leader sequence of EAV according to the manufacturer's protocol (Roche). The hybridized probe was then detected by anti-DIG-alkaline phosphatase. The CDP-Star alkaline phosphatase substrate and DIG Luminescent detection kit was used for visualization of DIG-labelled probe. Luminescence was detected by exposure of Kodak BioMax light film.
RESULTS
Phylogenetic relationships among the ORF5 sequences of viruses contained in the semen of carrier stallions with other European and North American strains of EAV Sequence and phylogenetic analyses were performed to characterize the EAV strains present in the semen of stallion CW. The ORF5 nucleotide sequences of EAV present in the semen of stallion CW in 1996, 1997, 1998, 2000 and 2001 were compared to those of viruses contained in the semen of nine other carrier stallions (Table 1) , and 29 other published complete ORF5 sequences of strains of EAV from North America and Europe (Balasuriya et al., 1995b (Balasuriya et al., , 1998 Hedges et al., 1999b; Larsen et al., 2001; Patton et al., 1999) . The viruses group into distinct clades of North American and European origin (Fig. 1) . The strains of EAV present in the semen of stallion CW and two other stallions (RS, P) were most closely related to EAV strains that originated in Europe (Fig. 1) , whereas the strains of EAV isolated from the semen of stallions D, E, FLS, KS, RC and S are all of North American origin. The ORF5 sequences of the virus strains present in the semen of each carrier stallion were clearly distinct from the other viruses isolated from the same animal (e.g. CW96 and CW01; WHB85 and WHB89). Furthermore, viruses from each stallion formed a distinct branch and in general genetic distances and branch length increased with time. These data clearly demonstrate that EAV evolves in the course of persistent infection of each stallion, with emergence of novel genetic variants.
Comparison of European and North American full-length EAV genome sequences
The entire genome of the strain of EAV present in semen collected from persistently infected stallion CW in 1996 (CW96) was directly amplified in overlapping fragments by RT-PCR using nine primer pairs (Table 2 ) and highfidelity proof-reading DNA polymerase enzymes. Sequences were determined by direct sequencing of RT-PCR fragments and can thus be assumed to reflect the consensus sequence of the virus population at the time of RNA extraction. Both strands of each RT-PCR fragment were sequenced and assembled into a single contiguous sequence using the Sequencher 3.1 program. The full-length nucleotide sequence of CW96 was compared to that of the published sequence of the prototype strain of EAV (EAV030; van Dinten et al., 1997). The complete CW96 nucleotide sequence was 85?6 % identical to that of the EAV030 reference virus. The CW96 genome was 12 708 nt in length and, therefore, longer than the published sequence of EAV030. The CW96 virus had a single 1 nt deletion (nt number G-138) and two 1 nt insertions (nt numbers T-156 and C-160) in its leader sequence as well as a 3 nt insertion in its ORF1a (nt C-1456, C-1457, G-1458). The 3 nt insertion increased the length of the ORF 1a and ORF1ab replicase polyproteins by one amino acid (to 1728 and 3176 aa respectively). There were 1505 differences (15?7 %) in the complete replicase gene of the CW96 virus as compared to EAV030. The majority of these nucleotide changes were localized to the nsp2-coding region of ORF1a (Table 3 and Fig. 2) . The CW96 nsp2 protein differed by Fig. 1 . Phylogenetic analysis of the ORF5 of EAV strains present in the semen of 10 carrier stallions and 29 previously published EAV strains (Balasuriya et al., 1995b (Balasuriya et al., , 1998 Hedges et al., 1999; Larsen et al., 2001; Patton et al., 1999 [these publications list specific GenBank accession numbers]). Sequential EAV strains from the same stallion are indicated by circles. (Fig. 2) . However, the putative nsp2 cysteine protease active sites at residues Cys-270 and His-332 were conserved. The other 11 nonstructural proteins of CW96 differed by only 1-19 amino acids (2?5-7?6 %) from those of the EAV030 virus. With the exception of the nsp7/8
cleavage site all predicted protease cleavage sites were absolutely conserved (Table 3 ; Snijder & Meulenberg, 1998; Ziebuhr et al., 2000) . The P19 residue of the predicted CW96 nsp7/8 cleavage site is a Cys (Cys-1679), whereas EAV030 contains a Gly, and only Ser and Ala have been observed as P19 alternatives thus far (Ziebuhr et al., 2000) . The CW96 sequence confirmed that the only EAV cleavage site that contains a Gln instead of a Glu as its P1 residue (the nsp10/11 cleavage site) is conserved among distantly related EAV isolates. Amongst the structural proteins, most of the variation between CW96 and EAV030 occurred in the four envelope glycoproteins (GP2, GP3, GP4 and GP5; encoded by ORFs 2b, 3-5 respectively; Table 3 ). The greatest variation occurred in the GP3 and GP5 proteins [24 and 21 aa respectively (~15 and~8 %)]. The N protein encoded by ORF7 was highly conserved and differed by only 2?7 % between the two viruses. The E and M (encoded by ORFs 2a and 6) proteins were also conserved and differed by~6 %.
The consensus nucleotide sequence of the EAV strain contained in the semen of stallion CW in 2001 (CW01) was determined using the same methods as outlined above. The CW01 nucleotide sequence was 85?7 % identical to that of the EAV030 sequence and was the same length as the CW96 virus. The number of amino acid differences in the various nonstructural and structural proteins as compared to the EAV030 virus is shown in Table 3 .
Comparative nucleotide and amino acid sequence analysis of viruses contained in the semen of stallion CW
To estimate the genetic variation of EAV during persistent infection, the complete nucleodide sequence of the virus contained in the semen of stallion CW in 2001 (CW01) was compared to the sequence of the 1996 virus from the same stallion (CW96). There were 178 nucleotide differences between the CW96 and CW01 consensus sequences (1?4 % difference). The replicase gene had only 1?2 % nucleotide variation between 1996 and 2001, and eight of the nonstructural proteins did not show any amino acid changes (nsp3, nsp5-10 and nsp12). Two of the four viral proteinases (nsp1 and nsp4) in CW01 had single amino acid substitutions as compared to CW96, whereas the other two proteinases (nsp2 and nsp11) respectively had three and two substitutions. The E, GP2b and N proteins were highly conserved during persistent infection, whereas the GP3, GP4 and GP5 proteins were more variable, although the GP4 protein was more conserved than either the GP3 or GP5 proteins.
To compare the selective pressure on individual EAV proteins the ratios of the number of nonsynonymous substitutions per nonsynonymous site (dN) and synonymous substitutions per synonymous site (dS) were estimated. The fixation of advantageous nonsynonymous substitutions will increase the dN/dS ratio (>1?0). In contrast, the presence of a large number of synonymous substitutions will decrease the dN/dS ratio (<1?0) and lead to negative (purifying) selection indicative of a reduced rate of evolution. In this study the dN/dS ratios estimated by pairwise comparison of all nonstructural and structural coding regions of these three viruses were consistently less than 1?0 (Table 3) . Therefore, these data suggest that positive selection did not significantly contribute to the nucleotide diversity of these viruses or to the establishment of persistent infection in stallion CW.
Emergence of novel phenotypic variants during persistent EAV infection of stallion CW
The GP5 protein, encoded by ORF5, contains the known neutralization determinants of EAV (Balasuriya et al., 1993 (Balasuriya et al., , 1995a (Balasuriya et al., , 1997 . In our previous studies we have shown that substitution of individual amino acids within the GP5 ectodomain occurs during persistent infection of stallions, leading to the emergence of viruses of different neutralization phenotype Hedges et al., 1999b) . Neutralization assays with a large panel of wellcharacterized mAbs and polyclonal equine sera confirmed that the nucleotide variation in ORF5 of the strains of EAV that were isolated from the semen of stallion CW (CW96 and CW01 respectively) correlated with phenotypic differences between these viruses (Table 4) . For example, mAb 6A2 did not neutralize the CW01 virus but neutralized the CW96 virus to a high titre (128). Similarly, some of the EAV strain-specific polyclonal equine sera neutralized the CW96 virus to a significantly higher titre (512) than the CW01 virus (Table 4) . Interestingly, the GP5 protein of the CW01 virus had three amino acid substitutions in neutralization site B (aa 61; ValRPhe) and C (aa 67-90; 71 GluRAsp and 84 PheRIle) as compared to the CW96 *mAb to the nucleocapsid (N) protein of EAV was used as a negative control.
DmAb to the nonstructural protein 1 (nsp1) of EAV was used as a negative control.
virus. These data further confirm that novel phenotypic variants of EAV emerge during persistent infection of stallions.
Evaluation of viruses contained in the semen of carrier stallions for the presence of DI RNAs
Serial cell culture passage of many viruses can result in the generation of DI viruses that modulate the replication of the wild-type (helper) virus and so facilitate viral persistence (Huang & Baltimore, 1970 , 1977 Roux et al., 1991; Frank, 2000) . DI RNAs were previously demonstrated after serial cell culture passage of undiluted EAV (Molenkamp et al., 2000) ; thus we speculated that a similar phenomenon might occur during persistent EAV infection of carrier stallions. In our study, intracellular RNA was isolated at tissue culture passage one (BHK1) and six (BHK6) of viruses isolated from stallion CW (CW96 and CW01), as well as 16 EAV isolates from nine other carrier stallions. The RNA was subjected to denaturing gel electrophoresis, and hybridized to a DIG-labelled oligonucleotide probe complementary to the 59 leader sequence of the EAV genome and all subgenomic mRNAs. Recombinant RNA derived from a previously described recombinant DI virus (Molenkamp et al., 2000) , as well as intracellular RNA isolated from BHK-21 cells infected with the EAV ATCC virus, were used as controls in the Northern hybridization assay. With the notable exception of the DI control, all RNA samples gave seven distinct bands on Northern hybridization assay, indicating the presence of the genomic (RNA1) and six subgenomic mRNAs (RNA2 through RNA7; Fig. 3 ). The DI control had an additional band that migrated between the 12?7 kb genome (RNA1) and subgenomic mRNA2 (3?2 kb) in the Northern hybridization assay, whereas additional RNA molecules indicative of the presence of DI particles were not detected in any other sample. Thus, deleted genomes were not present in substantial quantities in semen samples collected from EAV carrier stallions, including semen samples collected immediately prior to cessation of virus shedding by individual carrier stallions.
DISCUSSION
As would be predicted for an RNA virus, EAV clearly evolves during persistent infection of carrier stallions. It has not previously been established which portions of the viral genome are especially prone to variation. Thus, we compared the complete genome sequence of viruses present in the semen of the same stallion (CW) in 1996 and 2001. We also used Northern blotting analysis to confirm that DI virus particles are unlikely to contribute to the peculiar persistent infection of the reproductive tract that occurs in EAV carrier stallions.
Previous studies have demonstrated that phylogenetic analysis based on ORF5 sequences can be used to trace the origin of EAV strains (Balasuriya et al., 1995b (Balasuriya et al., , 1998 Larsen et al., 2001; Stadejek et al., 1999) . The phylogenetic analyses of virus strains present in the semen of stallion CW confirmed that this stallion was infected with a European strain of EAV, which is consistent with the fact that stallion CW was imported to North America from Europe as a mature stallion. Full-length nucleotide sequences of viruses contained in the semen of stallion CW were only 85?6 % (CW96) and 85?7 % (CW01) identical to the published sequence of the prototype laboratory strain of EAV (EAV030), which is derived from the original isolate of EAV that was made from an aborted fetus in Bucyrus, Ohio (Doll et al., 1957) . We previously have shown that European strains of EAV are~85 % identical to North American viruses based on their ORF5 sequences (Balasuriya et al., 1995b) . Thus, data from this present study further confirm that North American and European strains of EAV are genetically distinct, but that they also are more closely related to each other than the two porcine arterivirus genotypes isolated from these two continents. In contrast to EAV, there is only 55-70 % nucleotide identity between the European and North American genotypes of PRRSV (Nelsen et al., 1999; Shen et al., 2000) .
Genetic variation among the viruses contained in the semen of stallion CW and the prototype EAV030 virus was especially marked in the ORF1a gene, particularly the region that encodes the nsp2 replicase subunit. An amino acid insertion and several highly variable regions were identified at aa 388-480 of the ORF1a protein. Interestingly, this region overlaps with the region in which a host cellspecific, internal cleavage site of nsp2 was previously observed , although its biological significance remains to be determined. This region of the nsp2 protein varies markedly in both size and sequence in other arteriviruses (Nelsen et al., 1999; Shen et al., 2000) . For example, a 36 aa insertion was previously described in the nsp2 protein of a vaccine strain of PRRSV (Shen et al., 2000) .
The sequence data obtained in this study clearly demonstrate that each of the nine ORFs of EAV may evolve at a different rate during persistent infection and that the greatest variation amongst ORFs encoding structural viral proteins occurs in ORFs 3 and 5 (which respectively encode the GP3 and GP5 envelope proteins of the virus; Table 3 ). The GP4 protein encoded by ORF4 was more conserved than GP3, which is consistent with our previous sequence analysis of ORFs 3 and 4 of EAV isolates from persistently infected stallions and from outbreaks of EVA (Hedges et al., 1999a ; J. F. Hedges & U. B. R. Balasuriya, unpublished results) . In a previous study we also demonstrated that loss or acquisition of glycosylation sites may occur in different EAV structural proteins during persistent infection of stallions , and that amino acid changes in the GP5 protein alter the neutralization phenotype of EAV (Hedges et al., 1999b; Balasuriya et al., 1997 Balasuriya et al., , 2001 ). The neutralization phenotype data obtained in this study with different viruses further confirm that novel phenotypic variants emerge during persistent EAV infection of carrier stallions.
Although small (3-40 nt) deletions have occasionally been detected by the sequencing of cloned and uncloned PCR products containing ORF5 from different EAV stains (Balasuriya et al., 1995a (Balasuriya et al., , 1997 Glaser et al., 1995; Hedges et al., 1999) , there are no reports of naturally occurring EAV DI particles. Molenkamp et al. (2000) documented the first arterivirus DI RNA (5?6 kb) by serial passage of a laboratory strain of EAV in BHK-21 cells. In this present study, nucleotide deletions were not detected after direct RT-PCR amplification and sequencing of ORF5 of strains of EAV contained in the semen of 10 persistently infected carrier stallions. Furthermore, Northern hybridization assay of intracellular RNA from BHK-21 cells infected with these EAV strains did not show any evidence of DI RNA even after serial cell culture passage at high m.o.i. These data suggest that viruses with substantial genome deletions are uncommon during persistent infection of the stallion, and that DI viruses are unlikely to be involved in either the maintenance or clearance of persistent EAV infection of the reproductive tract of carrier stallions.
In summary, the data from the present study confirm that the genomic sequence of North American and European strains of EAV can differ by approximately 15 %. The data further confirm that EAV evolves in the course of persistent infection of carrier stallions and that variation is especially marked in the nsp2, GP3 and GP5 proteins. With the notable exception of GP5, however, the biological significance of this variation in individual EAV proteins is undetermined.
